Nur-Vaizura Mohamad
National University of Malaysia
18 Papers
39 Citations
Nur-Vaizura Mohamad is an academic researcher from National University of Malaysia. The author has contributed to research in topics: Medicine & Osteoporosis. The author has an hindex of 9, co-authored 18 publications.
Chat about Author
Papers
A concise review of testosterone and bone health.
TL;DR: It is shown that maintaining optimal level of androgen is essential in preventing osteoporosis and its complications in elderly men and both androgen and estrogen were indispensable for bone formation.
The relationship between circulating testosterone and inflammatory cytokines in men.
Nur-Vaizura Mohamad,Sok Kuan Wong,Wan Nuraini Wan Hasan,James Jam Jolly,Mohd Fozi Nur-Farhana,Soelaiman Ima-Nirwana,Kok-Yong Chin +6 more
TL;DR: In conclusion, testosterone may possess anti-inflammatory properties but its magnitude is debatable and more evidence is needed to validate the use of testosterone as a marker and in the management of chronic inflammatory diseases.
246
Prostate Cancer and Bone Metastases: The Underlying Mechanisms.
Sok Kuan Wong,Nur-Vaizura Mohamad,Tijjani Rabiu Giaze,Kok-Yong Chin,Norazlina Mohamed,Soelaiman Ima-Nirwana +5 more
TL;DR: The possible molecular mechanisms involved in governing bone metastases driven by prostate cancer are outlined, which further provide the basis in searching for new molecular targets for the development of potential therapy.
154
Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence.
TL;DR: The focus of the current review is to examine the relationship between estrogen deficiency, oxidative stress and inflammation, and the impacts of these phenomena on skeletal health in postmenopausal women.
77
Potential Role of Tocotrienols on Non-Communicable Diseases: A Review of Current Evidence
Sok Kuan Wong,Yusof Kamisah,Norazlina Mohamed,Norliza Muhammad,Norliana Masbah,Nur Azlina Mohd Fahami,Isa Naina Mohamed,Ahmad Nazun Shuid,Qodriyah Mohd Saad,Azman Abdullah,Nur-Vaizura Mohamad,Nurul 'Izzah Ibrahim,Kok-Lun Pang,Yoke Yue Chow,Benjamin Ka Seng Thong,Shaanthana Subramaniam,Chin Yi Chan,Soelaiman Ima-Nirwana,Kok-Yong Chin +18 more
TL;DR: The positive outcomes of T3 treatment obtained from the preclinical studies warrant further validation from clinical trials, particularly in prevention or treatment of non-communicable diseases (NCDs), including cardiovascular, musculoskeletal, metabolic, gastric, and skin disorders.
71